Chief Medical Officer

Executive Assistant To Chief Executive Officer

The biggest biotech funding rounds in September 2025

Transcript : Mineralys Therapeutics, Inc. Presents at H.C. Wainwright 27th Annual Global Investment Conference, Sep-09-2025 09

Mineralys Therapeutics Completes Enrollment in Phase 2 EXPLORE-OSA Trial of Lorundrostat in Obstructive Sleep Apnea and Hypertension

6 Stocks Goldman Sachs Says Are Poised For Potential Acquisition In Next 12 Months — Including A Huge 200% Winner

Director/ Sr. Director, HCP Marketing

Mineralys Therapeutics is a publicly traded, clinical-stage biotechnology company focused on developing medicines for diseases caused by elevated aldosterone. The Director/Sr. Director, HCP Marketing will lead healthcare professional brand strategy and go-to-market initiatives, requiring deep experience in HCP marketing and launch planning.

Sign up with Google

Sign in with Google